Novel In-Clinic Use of Levodopa Inhalation Powder (CVT-301) as an Outpatient Diagnostic Tool for Parkinson's disease (PD)

被引：0
|
作者：
Afshari, Z.
Nguyen, N.
Afshari, M.
机构：
来源：
MOVEMENT DISORDERS | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
817
引用
收藏
页码：S368 / S368
页数：1
相关论文
共 50 条
  • [41] UPDRS MOTOR-SCORE IMPROVEMENT AFTER CVT-301 TREATMENT IS ASSOCIATED WITH IMPROVED SCORES IN PARKINSON'S DISEASE QUESTIONNAIRE (PDQ-39) ACTIVITIES OF DAILY LIVING
    Hauser, R. A.
    Klingler, M.
    Abeynayake, I.
    Roberts, H.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E68 - E68
  • [42] Improvement in Unified Parkinson's Disease Rating Scale Motor Scores (UPDRS-III) After CVT-301 Treatment is Associated With Improved Scores in the Parkinson's Disease Questionnaire Activities of Daily Living (PDQ-39ADL)
    Abeynayake, Iresha
    Hauser, Robert
    Klingler, Michael
    Roberts, Holly
    NEUROLOGY, 2021, 96 (15)
  • [43] The Contribution of Cognitive and Affective Factors to Balance Control in People with Parkinson's disease (PD) Attending an Outpatient Clinic
    Spasova, E.
    O'Keeffe, C.
    Blanco-Campal, A.
    Inocentes, J.
    Fearon, C.
    Reilly, R.
    MOVEMENT DISORDERS, 2024, 39 : S184 - S185
  • [44] Performance of a Smartphone-based Oculomotor Test as a Diagnostic Tool for Parkinson's disease (PD)
    Edwards, C.
    Zirra, A.
    John, I. A.
    Bogucki, A.
    Torricelli, R.
    Kenny, J.
    Ganesh, S.
    Dey, K.
    Haque, T.
    Gallagher, D.
    Budu, C.
    Simonet, C.
    Wlodarski, M.
    Neffendorf, J.
    Chrapkiewicz, R.
    Manohar, S. G.
    Noyce, A. J.
    MOVEMENT DISORDERS, 2024, 39 : S562 - S562
  • [45] Darkening of white hair in Parkinson's disease during use of levodopa rich Mucuna pruriens extract powder
    Munhoz, Renato P.
    Teive, Helio A. G.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (02) : 133 - 133
  • [46] Subgroup analyses by Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) of patients treated with levodopa inhalation powder 84mg or placebo to treat OFF symptoms in patients with Parkinson's disease (PD)
    Grosset, D.
    Zhao, P.
    Marini, R.
    Cohen, R.
    Blank, B.
    MOVEMENT DISORDERS, 2022, 37 : S329 - S330
  • [47] Inhaled dry powder apomorphine (VR040) for 'off' periods in Parkinson's disease: an in-clinic double-blind dose ranging study
    Grosset, K. A.
    Malek, N.
    Morgan, F.
    Grosset, D. G.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (03): : 166 - 171
  • [48] Pilot study to investigate the use of in-clinic sensing to identify optimal stimulation parameters for deep brain stimulation therapy in Parkinson's disease
    Lewis, S.
    Ojemann, S.
    Kramer, D.
    Hirt, L.
    Radcliffe, E.
    Case, M.
    Becker, A.
    Raike, R.
    Thompson, J.
    Kern, D.
    MOVEMENT DISORDERS, 2022, 37 : S604 - S604
  • [49] Pilot Study to Investigate the Use of In-Clinic Sensing to Identify Optimal Stimulation Parameters for Deep Brain Stimulation Therapy in Parkinson's Disease
    Lewis, Sydnei
    Radcliffe, Erin
    Ojemann, Steven
    Kramer, Daniel R.
    Hirt, Lisa
    Case, Michelle
    Holt-Becker, Abbey B.
    Raike, Robert
    Kern, Drew S.
    Thompson, John A.
    NEUROMODULATION, 2024, 27 (03): : 509 - 519
  • [50] Skin biopsy in patients with Parkinson's disease: A novel diagnostic tool for evaluation of autonomic impairment
    Djaldetti, R
    Dabby, R
    Shachamurov, M
    Treves, T
    Melamed, E
    Avinoach, I
    MOVEMENT DISORDERS, 2002, 17 : S122 - S122
12345